18Other financial assets
|
|
|
2021 |
||||||
|
millions of CHF |
|
Financial assets at fair value through profit and loss |
|
Financial assets at fair value through other comprehensive income |
|
Financial assets at amortized costs |
|
Total |
|
Balance as of January 1 |
|
10.4 |
|
– |
|
305.3 |
|
315.7 |
|
Derecognized as discontinued operations |
|
–0.0 |
|
– |
|
–0.4 |
|
–0.4 |
|
Recognized through Applicator Systems division spin-off |
|
– |
|
21.9 |
|
434.2 |
|
456.2 |
|
Additions |
|
0.9 |
|
– |
|
5.3 |
|
6.2 |
|
Repayments |
|
– |
|
– |
|
–733.0 |
|
–733.0 |
|
Changes in fair value |
|
0.3 |
|
0.6 |
|
– |
|
0.9 |
|
Currency translation differences |
|
–0.7 |
|
– |
|
–0.1 |
|
–0.8 |
|
Balance as of December 31 |
|
10.9 |
|
22.5 |
|
11.3 |
|
44.7 |
|
– thereof non-current |
|
8.9 |
|
– |
|
9.1 |
|
18.0 |
|
– thereof current |
|
2.0 |
|
22.5 |
|
2.2 |
|
26.7 |
|
|
|
2020 |
||||||
|
millions of CHF |
|
Financial assets at fair value through profit and loss |
|
Financial assets at fair value through other comprehensive income |
|
Financial assets at amortized costs |
|
Total |
|
Balance as of January 1 |
|
10.3 |
|
– |
|
59.8 |
|
70.1 |
|
Changes in scope of consolidation |
|
– |
|
– |
|
0.1 |
|
0.1 |
|
Additions |
|
4.0 |
|
– |
|
369.7 |
|
373.8 |
|
Disposals |
|
– |
|
– |
|
–123.3 |
|
–123.3 |
|
Reclassifications |
|
–4.1 |
|
– |
|
–0.4 |
|
–4.4 |
|
Changes in fair value |
|
0.1 |
|
– |
|
– |
|
0.1 |
|
Currency translation differences |
|
–0.0 |
|
– |
|
–0.7 |
|
–0.7 |
|
Balance as of December 31 |
|
10.4 |
|
– |
|
305.3 |
|
315.7 |
|
– thereof non-current |
|
8.7 |
|
– |
|
2.0 |
|
10.6 |
|
– thereof current |
|
1.7 |
|
– |
|
303.3 |
|
305.1 |
Financial assets that belong to the category “financial assets at fair value through profit and lossˮ include investments in equity securities.
Financial assets that belong to the category “financial assets at fair value through other comprehensive income” include CHF 22.5 million (2020: CHF 0.0 million) investments in medmix shares. Through the Applicator Systems spin-off, the group received one medmix Ltd share for one treasury share held, in total 498’736 shares. The financial investment in medmix Ltd was recognized at its fair value based on the share price of medmix Ltd on September 30, 2021 (a Level 1 hierarchy valuation). Management has designated this investment at fair value through other comprehensive income.
Financial assets at amortized costs increased by CHF 434.2 million through the Applicator Systems division spin-off. Prior to the spin-off, these were intercompany borrowings between the group and Applicator Systems entities, which following the spin-off were classified as financial assets at amortized costs.
Financial assets at amortized costs include CHF 0.0 million (2020: CHF 302.4 million) investments in fixed-term deposits with maturities between 4 and 12 months at the date of acquisition.